Osteoarthritis is more than wear and tear. An Advanced Science study in mice and human synovium finds that HMGCR, the statin-targeted enzyme of cholesterol synthesis, runs too hot in synovial fibroblasts, overproduces cholesterol, drives cellular senescence, and fuels synovitis and cartilage breakdown; local joint knockdown of HMGCR in mice reverses senescence and eases pain and cartilage loss.
## Against the hardest breast cancer, a desert shrub hits two brakes at once If you have heard that breast cancer can be treated by "reading its hormone recept
mTORC1 is the most famous molecular switch in aging research, yet how it gets turned on at the Golgi has stayed murky. A 2026 study shows the Golgi protein YIF1A recruits RNF126 to degrade G3BP1/2, releasing the brake on mTORC1; cells with YIF1A knocked down resist induced senescence, and worm experiments reveal the pathway tunes lifespan in both directions.
Ferroptosis and pyroptosis are two forms of cell death that rupture and splash pro-inflammatory cargo onto neighboring cells. Four 2026 studies — spanning skin fibroblasts, brain microglia and neurons, and diabetic kidneys — trace the same self-amplifying loop and identify three brake points: HIF-1α, stem-cell-secreted TSG-6, and puerarin's control of caspase-1.
Senescent cells pile up because aging immune systems stop clearing them efficiently. Instead of killing every senescent cell, new 2026 reviews argue for senomorphic strategies that quiet SASP-driven inflammation.
Senescent cells have been the bad neighbor of aging biology for nearly two decades. Three 2026 papers flip the question: before we rush to clear them, do we even know what they are? Turns out we barely did — and now that we're learning, the picture is far less black and white.